检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:赵剑虹[1] 蒋希菁[1] 沈岚[1] 姚守珍[1] 陈丽[1]
机构地区:[1]浙江省杭州市红十字会医院妇产科,浙江杭州310003
出 处:《中国内镜杂志》2014年第4期372-375,共4页China Journal of Endoscopy
摘 要:目的探讨腹腔镜下子宫动脉阻断联合腺肌瘤剥除术治疗子宫腺肌瘤的可行性。方法选取2010年1月~2012年12月于该院进行诊治的68例子宫腺肌瘤患者为研究对象,将其随机分为对照组(腹腔镜下腺肌瘤剥除术组)34例和观察组(腹腔镜下子宫动脉阻断联合腺肌瘤剥除术组)34例,然后将两组患者的术中出血量、手术时间、术后胃肠道功能恢复时间、子宫缩小幅度及痛经程度、复发率进行比较。结果观察组在术中出血量、术后胃肠道功能恢复时间、子宫缩小幅度及痛经程度、复发率方面均明显好于对照组,而手术时间则长于对照组,均P〈0.05,差异均有显著性。结论腹腔镜下子宫动脉阻断联合腺肌瘤剥除术治疗子宫腺肌瘤的临床疗效相对较好,更有助于患者的尽快康复和复发率的控制。[Objective]To investigate the feasibility of laparoscopic uterine artery blockage combined with stripping adenomyoma in the treatment of patients with endometrioma.[Methods]68 patients with endometrioma in our hospital from January 2010 to December 2012 were selected as research subjects, and they were randomly divided into control group(laparoscopic stripping adenomyoma group) 34 cases and observation group(laparoscopic uterine artery blockage combined with stripping adenomyoma group) 34 cases,then the intraoperative blood loss, operative time, postoperative recovery time of gastrointestinal function, size of uterine range and degree of dysmenorrhea, relapse rate of two groups were compared.[Results]The intraoperative blood loss, postoperative recovery time of gastrointestinal function, size of uterine range and degree of dysmenorrhea, relapse rate of observation group were all obvious better than those of control group, but the operative time was longer than that of control group, all P〈0.05, there were all significant differences. [Conclusion]The clinical effect of laparoscopic uterine artery blockage combined with stripping adenomyoma in the treatment of patients with endometrioma is relatively better, and it is more helpful for the rehabilitation and the controlling of relapse rate.
关 键 词:腹腔镜下子宫动脉阻断 腺肌瘤剥除术 子宫腺肌瘤
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.200